Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results
Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102, demonstrating potent antitumor...
Search results for "FDA"
Expanded Health Insurance Coverage Lowers Barrier to Care for Rare Heart and Kidney Disorder
Patients suffering from light-chain amyloidosis, a rare and debilitating blood disorder that causes abnormal proteins to accumulate in vital organs,...
South Korean Biotechs Race to Conquer the Untapped Global MASH Market
Fat accumulation in the liver can trigger severe inflammation even in individuals who completely abstain from alcohol.
Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise
Early clinical data point to extended survival and the rare possibility of complete remission in metastatic pancreatic...
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?
A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World...
Can Eye Health Be Reversed?... Clues Found to ‘Retinal Rejuvenation’
A potential way to return aged cells in the eye to a more youthful state has been identified.
Bruising and Bleeding Gums? Your Medication and Supplement Combo Could Be the Culprit
It is common practice to take omega-3 or vitamin E for cardiovascular support while maintaining a daily anticoagulant...
Black Coffee and Diabetes: A Guide to Drinking Wisely Amid the 'Diabetes Surge'
Many people start their day with a cup of coffee, and Koreans’ affinity for the beverage is particularly notable.
Taking Wegovy or Mounjaro? Seek Immediate Medical Attention if ‘These Symptoms’ Appear
As anti-obesity medications for weight loss and blood sugar control gain popularity, monitoring and managing potential...
YuhanUSA and Huinno Partner to Launch AI-Powered ECG Monitoring in the U.S.
YuhanUSA, the U.S. subsidiary of Yuhan Corporation, announced on the 30th that it has signed a strategic business...